HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Tesaglitazar

HCID 208901
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
251565-85-2
Standard SMILES
CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O
InChIKey
CXGTZJYQWSUFET-IBGZPJMESA-N
Molecular formula
C20H24O7S
Average molar mass
408.5 g/mol
Monoisotopic mass
408.12427427

Overview

Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.

Names & identifiers

Preferred name
Tesaglitazar
IUPAC
(2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
English name
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl]-propionic acid
Molecular formula
C20H24O7S
Molecular weight
408.47

Names & synonyms

Tesaglitazar251565-85-2GalidaAZ-242AR-H039242XXBR-44608(s)-2-ethoxy-3-(4-(2-(4-methylsulphonyloxyphenyl)ethoxy)phenyl)propanoic acidAR-H-0392426734037O3L(2S)-2-Ethoxy-3-(4-(2-(4-((methylsulfonyl)oxy)phenyl)ethoxy)phenyl)propanoic acid(2S)-2-ETHOXY-3-[4-(2-{4-[(METHYLSULFONYL)OXY]PHENYL}ETHOXY)PHENYL]PROPANOIC ACID(S)-2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid
Show more names
GalidAZ 242AR-H 039242TesaglitizarAR-H 039242XXTesaglitazar, 10 mM in DMSO2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acidDTXSID4048773tesaglitazarum(2S)-2-Ethoxy-3-[4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]phenyl]propanoic acidRefChem:896625DTXCID401508653675-830-5(S)-2-Ethoxy-3-(4-(4-((methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid

Properties

Computed structural properties

XLogP
3.5
Topological polar surface area
108 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
7
Rotatable bonds
11
Heavy atoms
28
Formal charge
0
Complexity
556

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
83 · 83-85°C
Boiling point
611 ℃ · 611℃
Density
1.278 · 1.278
Flash point
324 ℃ · 324℃
storage temp.
2 · 2-8°C
solubility
Chloroform (Slightly), Methanol (Slightly)
form
Solid
pka
3.62 · 3.62±0.10(Predicted)
color
White
Merck
14 · 14,9177
InChI
1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1
InChIKey
CXGTZJYQWSUFET-IBGZPJMESA-N
SMILES
O=S(OC1=CC=C(CCOC2=CC=C(C[C@H](OCC)C(O)=O)C=C2)C=C1)(C)=O

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (33.3%)

Safety data

wgk
WGK 3
hs_code
2930909099
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

PharmacodynamicsTreatment with tesaglitazar lowered fasting plasma glucose, improved glucose tolerance, substantially reduced fasting and postload insulin levels, and markedly lowered fasting TG and improved lipid tolerance.

Applications

UsesDual -acting peroxisome proliferator-activated receptor (PPAR) a and agonist. Antidiabetic

Upstream & downstream products

Upstream raw materials

(S)-2-Ethoxy-3-[4-(2-{4-Methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid ethyl ester1,4-DioxaneHeptaneBenzenepropanamide, α-ethoxy-N-[(1R)-2-hydroxy-1-phenylethyl]-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (αS)-Ethyl acetateAcetic acidSulfuric acid

Related reactions

5 records
New reaction record
HRID 6978 reaction equation
HRID 6978As product
HRID 432073 reaction equation
HRID 432073As product
HRID 432080 reaction equation
HRID 432080As product
HRID 1384419 reaction equation
HRID 1384419As product
HRID 1861212 reaction equation
HRID 1861212As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
251565-85-2
PubChem CID
208901
DTXSID
DTXSID4048773
ChEMBL
CHEMBL282686
UNII
6734037O3L
EC Number
675-830-5
Nikkaji
J1.856.738E
FDA UNII
6734037 O3L · 6734037O3L
Comptox DTXSID
4048773 · DTXSID4048773
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
280 · P280-P305+P351+P338
WGK Germany
3 · WGK 3
HS Code
2930909099 · 2930909099
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral